Mr. Zohar Krivorot reports

CANNARA ANNOUNCES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE

Cannara Biotech Inc. has received conditional approval to uplist its common shares to the Toronto Stock Exchange from the TSX Venture Exchange.

"Today's announcement represents a significant validation of the vision and hard work our entire team has poured into building Cannara. I want to thank our employees, shareholders and partners who have supported us on this journey. We look forward to completing the final listing requirements and joining the TSX, where we believe their enhanced platform will provide additional visibility to potential new investors and greater liquidity for our shareholders as we continue to execute on our brand, growth and profitability strategy," commented Zohar Krivorot, founder and chief executive officer of Cannara.

Final approval of the uplisting is subject to the company meeting certain conditions required by the TSX. Upon completion of the final listing requirements, the company's common shares will be delisted from the TSX-V. Cannara common shares will continue to trade under the stock symbol LOVE upon listing on the TSX. The company will issue a press release once the expected commencement date for trading of Cannara's common shares on the TSX is confirmed.

About Cannara Biotech Inc.

Cannara is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two megafacilities based in Quebec spanning over 1.6 million square feet, providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price.

We seek Safe Harbor.